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Abstract
The world has been embroiled in a deadly and volatile public health crisis. The novel
coronavirus disease 2019 (COVID-19), as a pandemic, has been rapidly affecting nations
throughout the world with such ferocity that governments and their public health authorities have
been forced to take drastic measures to contain the spread. Yet, despite the aggressive preventative
measures in place, COVID-19 has propagated exponentially throughout the world. In response,
we conducted an epidemiological study evaluating cumulative incidence, incidence rate, and
mortality rate of COVID-19 to better understand the potential modes of disease transmission.in
select countries experiencing a high burden of the disease. Currently, the accepted mode of disease
transmission is by respiratory droplets containing the virus. Here we provide epidemiological data
in conjunction with molecular mechanisms of this Severe Acute Respiratory SyndromeCoronavirus-2 (SARS-CoV-2) and explain the possible alternative modes of disease transmission
for COVID-19. Results from this investigation showed that despite aggressive droplet
precautionary measures in place the rate of COVID-19 transmission remains exponentially high.
Our study indicates that COVID-19 has a high probability of transmission through other routes,
such as indirect routes; viz, fomites and aerosols. In conclusion, additional preventative measures
are needed to slow the spread of COVID-19.

Introduction
The world is in the middle of a historic public health crisis. As of March 30th, 2020, over a
third of the population in the United States were under “stay at home” orders given by state
governors to protect the vulnerable and the unexposed. Unprecedented steps have been taken by
governments globally to contain the novel coronavirus disease 2019 (COVID-19), a rapidly
spreading pandemic. This has resulted in more than 690,000 cases and over 33,000 deaths
worldwide (Table 1). The index case of the disease, caused by the Severe Acute Respiratory
Syndrome- Coronavirus-2 (SARS-CoV-2) was identified more than three months ago. Since then,
public health authorities worldwide have taken aggressive measures to blunt the exponential
spread of this coronavirus. Furthermore, several nations including Italy, Spain, and France have
imposed nation-wide lockdown measures to enforce social distancing to further prevent the spread
of COVID-19 in their respective countries.
While preventative measures have been imposed globally, the observed propagation of
COVID-19 has noticeable differences among select nations. Epidemiologic data shows that some
nations have exponential increases in disease incidence, while others seem to have “flattened the
curve.” This raises the questions of whether a full scientific understanding of the modes of
transmission of this disease has yet to be attained, and thus whether there are more effective ways
to prevent its spread. This brings us to the fundamental question of whether COVID-19 spread
through droplets alone.
To answer this question we performed an epidemiological study evaluating at total numbers
of COVID-19 cases, incidence rates, total mortality, and mortality rates in countries that were
considered epicenters for COVID-19. Our Current epidemiological data in conjunction with
molecular characteristics of SARS-CoV-2 suggests that it may spread through indirect

transmission modes as well. In addition, these data presented herein demonstrate the increased
virulence characteristics and the ability of this novel coronavirus to remain viable on various
environmental surfaces from hours to days compared to the previous SARS-CoV-1. These
molecular properties and data presented herein, likely explain how this novel coronavirus may also
be transmissible by indirect methods of transmission including fomites and aerosols, in addition
to respiratory droplets.
Public health agencies and authorities play a significant and role in controlling and
mitigating the effects of pandemics such as this one. Public health leaders develop and implement
aggressive interventions to reduce the exponential rise in incidence rates of disease transmission.
Policy regarding these reduction measures has been guided by observations in health outcomes
following the 1918 influenza pandemic. Importantly, during this pandemic, some U.S. cities chose
more effective measures to address the spread of the disease, resulting in observable differences
in mortality rates across the nation [1]. One example of this was the quarantining of people within
homes. Another was the deliberate reduction in space between persons; a practice now known as
social distancing. Social distancing is an evidence-based practice to help prevent the transmission
of pathogens that are known to spread from person to person within a 3 to 6 feet distance through
respiratory droplets [2, 3]. This practice requires individuals in a community to choose behaviors
that increase the distance between themselves and others (infected, asymptomatic carriers, or noninfected). This helps reduce the transmission of respiratory droplets containing SARS-CoV-2 and
slows the incidence of the disease by reducing the opportunities for potential viral exposures.
Documented responses such as the previous provide great examples of how integral the
public health system and policies are to the proper function of medical and healthcare systems.
Acting swiftly and mobilizing precautionary measures, can substantially aid in flattening the

disease incidence curve. Thereby reducing the number of critically ill patients who will need
medical treatment -all at the same time. This, in turn, reduces the burden on the healthcare system
that takes care of patients presenting with the most feared complication of COVID-19, i.e.; severe
bilateral pneumonia [4]. This concept now widely referred to as “flattening the curve” gives
critically ill patients a fighting chance to survive by obtaining life-saving supportive therapy in
hospitals. This, therefore, significantly reduces the mortality rate [1]. If the number of critically ill
patients is greater than what can be accommodated in hospitals, many more patients will die due
to the lack of life-saving medical attention.

Methods
Epidemiological study design
This was a cross-sectional study looking at the cumulative incidence of COVID-19 on a
daily interval from the 20th of January to the 30th of March. Incidence data for COVID-19 cases
and deaths were obtained from the COVID-19 Situation Reports provided by the WHO
(https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports). For this
study COVID-19 Situation Reports, 1 to 70, published from the 20th of January to the 30th of March
were used. These data sets included the number of cumulative cases and the number of cumulative
deaths attributed to COVID-19, reported each day. Cases and deaths were stratified according to
countries and different regions of the world. For this study we look at countries most affected by
the COVID-19 pandemic, also referred to as disease epicenters.
Cumulative Incidence and Incidence Rate of COVID-19
Cumulative incidence of COVID-19 was calculated using the case total data from WHO
COVID-19 Situation Reports 1 to 70. Each of these reports provided the cumulative incidence of

COVID-19 stratified according to countries and the cumulative incidence worldwide. To calculate
the daily incidence rate of COVID-19 from the 20th of January to the 30th of March, the case total
corresponding that day was subtracted by the case total from the previous day. The incidence rates
are presented over 24 hours in this study. The population at risk was considered to be the total
population of the respective country, as COVID-19 is a new disease with no prior immunity.
Total number of deaths and Mortality Rate of COVID-19
The total number of deaths due to COVID-19 was obtained from WHO COVID-19
Situation Reports 1 to 70. Each of these reports provided the total number of deaths caused by
COVID-19 stratified according to countries and the total number of deaths worldwide. To calculate
the mortality rate of COVID-19 from the 20th of January to the 30th of March, the ratio of the total
number of death and the case total of COVID-19 corresponding that day was taken. The mortality
rates are reported for the period from the 20th of January to the 30th of March (Table 1). Mortality
rates of COVID-19 are reported worldwide and for select countries from various regions as
designated by the WHO.
Representation of Study Results
The case and death number and data obtained from the WHO COVID-19 Situation Reports
1 to 70 were analyzed and graphed using Microsoft Excel software. The case totals and cumulative
deaths are represented as scatter plots. The number of new cases and deaths due to COVID-19
each day are represented as bar graphs. These results are organized according to country and
regions of the world. The four regions analyzed in this study are the Western Pacific region,
European region, East-Asian region and the Mediterranean region.

Results and Discussion
Transmission of COVID-19 and Preventative Measures in Place
The current consensus regarding the transmission of SARS-CoV-2 is that it spreads person
to person through respiratory droplets [5, 6]. Precautions to prevent the spread by droplets as
recommended by both the Centers for Disease Control and Prevention (CDC) and the World Health
Organization (WHO) are to (1) wash hands with soap, (2) avoid touching viral entry points, such
as eyes, nose, and mouth, (3) cover the mouth when coughing or sneezing, (4) wear a facemask to
cover both the mouth and nose if sick and (5) practice social distancing by putting 6 feet of distance
between individuals. In addition to these precautions, government-mandated social distancing
measures such as (6) state lockdowns and (7) “stay at home” orders are effective ways to minimize
the spread of SARS-CoV-2 through droplet transmission. Despite all these aggressive
precautionary measures, SARS-CoV-2 has succeeded to establish an exponentially growing
pandemic that has spread to almost every nation in the world (Figure 1). The United States and
Italy have already passed China in the number of cases and deaths caused by COVID-19 while
Spain was not far behind (Figure 2).

Figure 1. The number of COVID-19 Cases and Deaths Worldwide. The global cumulative case
total of COVID-19 (SARS-CoV-2) as reported by the World Health Organization (WHO) daily
COVID-19 Situation Reports (1 – 63). This includes cases reported from the 21st of January to the
30th of March 2020. (a) The total number of COVID-19 cases. (b) The number of new cases
confirmed each 24 h period. (c) The total number of deaths associated with COVID-19. (d) The
number of new deaths reported each 24 h period.

The outbreak on the Diamond Princess Cruise Ship
Certain epidemiological observations may provide evidence to suspect that the spread of
SARS-CoV-2 may not be limited to respiratory droplets alone. For example, on the 4th of February
2020, the Diamond Princess Cruise ship carrying 3711 passengers and crew members reported 10
cases testing positive for COVID-19 after their 14-day voyage. As a response to this, the ship was
quarantined for 14 days while docked off the coast of Japan. Following this quarantine period, a
total of 634 cases reportedly tested positive for COVID-19, despite droplet precautions and social

distancing principles practiced on board [7]. In retrospect, public health officials acknowledge this
was not the best practice implemented to contain COVID-19. Additionally, public health officials
responded differently to the Grand Princess Cruise ship off the coast of Oakland California, based
on suspicions that the dramatically widespread transmission of fomites or COVID-19 aerosols may
have been exacerbated by interconnected central ventilation between ship cabins [8]. Public health
officials removed all susceptible and unexposed passengers from this cruise ship, which resulted
in a significantly lower number of COVID-19 cases [8].

Figure 2. The number of COVID-19 Cases and Deaths in the United States, Italy, Spain, and
China. The cumulative case total of COVID-19 (SARS-CoV-2) for each country as reported by
the World Health Organization (WHO) daily COVID-19 Situation Reports (1 – 63). This includes
cases reported from the 21st of January to the 30th of March 2020. (a) The total number of COVID19 cases. (b) The number of new cases confirmed each 24 h period. (c) The total number of deaths
associated with COVID-19. (d) The number of new deaths reported each 24 h period.

The Outbreak in Italy and Other European Countries
Tragically, another story that is unfolding in the COVID-19 pandemic has been occurring
within the country of Italy, which currently maintains a mortality rate of 11.0% (Table 1). Once
the number of COVID-19 positive cases surpassed 5000, the government of Italy imposed a
nationwide lockdown measure on the 9th of March (Figure 3 a and b, black solid arrow). However,
even after these measures were in place for over two weeks (Figure 3 a and b, black dotted arrow),
the number of cases of COVID-19 continued to rise exponentially, nearing 100,000 cases by the
30th of March (Table 1 and Figure 3). This may suggest that Italy responded far too late to
implement preventative measures that could have flattened the curve. Or, this example may suggest
that even amidst the aggressive precautionary measures taken to reduce droplet transmission, that
aerosol transmission may have also occurred, which may more effectively explain this outcome.
These observations are not limited to just Italy. Most of the European nations are currently
experiencing an exponential increase in the incidence rate of COVID-19 despite many stringent
precautionary measures employed over the past several weeks (Figure 3). These epidemiological
observations in the rapid spread of the disease across nations practicing droplet precautions
strongly suggest the premise of this investigation that other alternative modes of disease
transmission are adding to the number of diagnosed cases worldwide.

Figure 3. The number of COVID-19 Cases and Deaths in 19 in Select Countries in the
European Region. The cumulative case total of COVID-19 (SARS-CoV-2) for each country as
reported by the World Health Organization (WHO) daily COVID-19 Situation Reports (1 – 63).
This includes cases reported from the 21st of January to the 30th of March 2020. (a) The total
number of COVID-19 cases. (b) The number of new cases confirmed each 24 h period. (c) The
total number of deaths associated with COVID-19. (d) The number of new deaths reported each
24 h period. The black solid arrow represents the day Italy entered a nationwide lockdown. The
black dotted line represents two weeks since the start of the lockdown measures, which overlaps
with the incubation period of SARS-CoV-2.

The Outbreak in Western Pacific Region
Despite having many of the early cases of COVID-19 in East Asian countries in the
Western Pacific Region, the rate of spread of SARS-CoV-2 has been controlled for the most part
(Figure 4). Apart from mainland China, where the index case of COVID-19 was identified, South

Korea (Republic of Korea) had the highest number of confirmed cases (Figure 4a). This was
largely due to the expanded screen measures and laboratory tests to confirm COVID-19 cases. This
is also reflected in the relatively low mortality rate observed in South Korea (1.6% mortality rate)
(Table 1 and Figure 4 c and d). Other countries in this region have had relatively low incidence
rates of the disease and indicate possible successful preventative measures in place.

Figure 4. The number of COVID-19 Cases and Deaths in 19 in Select Countries in the
Western Pacific Region. The cumulative case total of COVID-19 (SARS-CoV-2) for each country
as reported by the World Health Organization (WHO) daily COVID-19 Situation Reports (1 – 63).
This includes cases reported from the 21st of January to the 30th of March 2020. (a) The total
number of COVID-19 cases. (b) The number of new cases confirmed each 24 h period. (c) The
total number of deaths associated with COVID-19. (d) The number of new deaths reported each
24 h period.

The Outbreak in South East Asia and Mediterranean Regions
Apart from Iran, the COVID-19 pandemic has not been widespread across South East Asia
and the Mediterranean region (Figure 5). There are many population dense countries in these two
regions, with India having a population of over 1.3 billion residents. At the current moment, it is
not completely clear as to why disparities exist in the transmission rates of COVID-19 among
different countries. However, the disease seems to be spreading globally with moving epicenters
for the disease. If Iran is any representation of how COVID-19 can spread in South East Asia and
Mediterranean regions, the next few months will be crucial for public health authorities to take the
necessary measures to mitigate the public health impact of COVID-19.

Figure 5. The number of COVID-19 Cases and Deaths in 19 in Select Countries in SouthEast Asia and the Eastern Mediterranean Regions. The cumulative case total of COVID-19
(SARS-CoV-2) for each country as reported by the World Health Organization (WHO) daily
COVID-19 Situation Reports (1 – 63). This includes cases reported from the 21st of January to the

30th of March 2020. (a) The total number of COVID-19 cases. (b) The number of new cases
confirmed each 24 h period. (c) The total number of deaths associated with COVID-19. (d) The
number of new deaths reported each 24 h period.

Molecular Basis of SARS-CoV-2 Virulence
Recent studies have indicated that SARS-CoV-2 demonstrated 10-20 times greater affinity
to angiotensin-converting enzyme 2 (ACE2) receptors compared to SARS-CoV-1, making it a
much more virulent virus [9, 10]. This means fewer SARS-CoV-2 virions are necessary to
establish an infection in humans. This in part, could explain the rapid spread of the disease
worldwide compared to the 2002-2003 SARS outbreak that infected approximately 8,100
individuals. The primary mode of transmission of SARS-CoV-1 in the 2002-2003 outbreak was
by respiratory droplets up to a distance of about 6 feet [3, 11]. However, SARS-CoV-1 has also
shown to be viable on a variety of common surfaces under environmental conditions up to 96 h
post-exposure [12, 13]. SARS-CoV-2 was recently shown to remain viable on average for about
6.8 h on plastic surfaces and about 5.6 h on stainless steel surfaces, and viable virions were detected
up to 72 h post-exposure [14]. These studies have demonstrated that SARS-CoV-2 can remain
viable in the environment much longer than most other viruses transmitted through respiratory
droplets.
The ability of SARS-CoV-2 to remain viable longer on surfaces taken together with its
higher virulence in establishing an infection makes it very likely that this coronavirus uses other
modes of transmission in addition to respiratory droplets (Figure 6). Remaining longer in the
environment may mean this coronavirus can easily transmit through indirect contact. This is can
be either a certain level of airborne spread or vehicle-borne (fomites) transmission. Pathogens like

influenza virus and rhinovirus that are usually spread through respiratory droplets have some
airborne transmission properties making it plausible that SARS-CoV-2 may have such
characteristics as well [2, 15, 16]. Such additional modes of transmission can help further explain
the observations made on the Diamond Princess Cruise ship, in Italy and other European nations.
On the cruise ship, contaminated surfaces and utensils (fomites), and aerosolized viral particles
traveling beyond 6 feet could have exacerbated the volatile spread of COVID-19. In Italy having
houses or other domiciles in close proximity to one another may have transmitted the disease even
with a limited level of aerosolization. This example may also greater explain the current
exponential spread of SARS-CoV-2 in many European nations and in the United States that are
aggressively practicing social distancing.

Figure 6. COVID-19 Potential Modes of Transmission. This illustration shows three potential
ways SARS-CoV-2 can spread from an infected host to a susceptible host. First, it is transmitted
person to person (direct contact) through respiratory droplets. These droplets can travel for
distances 6 feet or less in air. Second, SARS-CoV-2 is likely transmitted through fomites (indirect

contact) for the duration it is viable on environmental surfaces. Third, it is also likely transmitted
through aerosols (indirect contact) for distances longer than 6 feet in the air. To establish an
infection, SARS-CoV-2 needs to first reach an entry point (eyes, nose or mouth) on a susceptible
host.

Widened Measures to Help Better Prevent the Spread of SARS-CoV-2
Today, the world is facing a certain deadly disease to which there is no cure currently nor
a vaccine. Based on the aforementioned findings, if SARS-CoV-2 is also transmitted through
indirect contact, greater and additional, yet practical methods of precaution must be taken. There
are ways to help prevent such spread. (1) First, it is important to follow all droplet precautions
including washing hands with soap or using an alcohol-based hand sanitizer for 20 to 40 seconds,
(2) protecting viral entry points, (3) covering one’s mouth when coughing or sneezing, and (4)
appropriate social/physical distancing. In addition, (5) constantly disinfecting contact surfaces can
eliminate the risk of fomite-based transmission. (6) Furthermore, to prevent the possible spread of
aerosolized SARS-CoV-2 infections, we will need to reevaluate; (i) the current recommendations
of 6 feet of physical separation between individuals but possibly increase it further, and (ii)
recommend the use of personal facemasks in areas where there is a high level of social activity.
Finally, in areas of increased risk of COVID-19 transmission such as hospitals and patient care
facilities, (7) an appropriately fitted N95 respiratory (facemask), with other personal protective
equipment (PPE) (e.g. eye shields, gowns and glows) and (8) expanded use of special air handling
and ventilation systems (e.g. AIIRs) that can appropriately purify circulating air in hospitals. This
can help contain and safely remove SARS-CoV-2 likely transmitted through aerosolization [17,
18].
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Table Legend
Table 1. Mortality Rates of COVID-19 as of March 23rd, 2020 in Select Regions and Countries.
Country
Western Pacific Region
China
South Korea
Japan
Malaysia
Singapore
Philippines
Australia
European Region
Italy
Spain
France
Germany
Switzerland
Netherlands
United Kingdom
South-East Asia Region
Thailand
India
Sri Lanka
Eastern Mediterranean Region
Iran
United Arab Emirates
North American Region
United States of America
Canada
Worldwide (All Cases Globally)

Number of Cases1

Mortality Rate (%)2

82447
9661
1866
2470
844
1418
3966

4.0
1.6
2.9
1.4
0.4
5.0
0.4

97689
78797
39642
57298
14274
10866
19526

11.0
8.3
6.6
0.8
1.8
7.1
6.3

1524
1071
120

0.6
2.7
0.8

38309
570

6.9
0.5

122653
5655
693224

1.7
1.1
4.8

1

Number of cases of COVID-19 as reported by the World Health Organization (WHO) in their
Coronavirus disease 2019 (COVID-19) Situation Report – 70, published on March 30th, 2020.
2

Mortality rate (%) calculated by taking the ratio of the total number of deaths and the total number
of cases reported by the WHO for each country in their Coronavirus disease 2019 (COVID-19)
Situation Report - 70 published on March 30th, 2020.

Figure Legend

Figure 1. The number of COVID-19 Cases and Deaths Worldwide. The global cumulative case
total of COVID-19 (SARS-CoV-2) as reported by the World Health Organization (WHO) daily
COVID-19 Situation Reports (1 – 63). This includes cases reported from the 21st of January to the
30th of March 2020. (a) The total number of COVID-19 cases. (b) The number of new cases
confirmed each 24 h period. (c) The total number of deaths associated with COVID-19. (d) The
number of new deaths reported each 24 h period.

Figure 2. The number of COVID-19 Cases and Deaths in the United States, Italy, Spain, and
China. The cumulative case total of COVID-19 (SARS-CoV-2) for each country as reported by
the World Health Organization (WHO) daily COVID-19 Situation Reports (1 – 63). This includes
cases reported from the 21st of January to the 30th of March 2020. (a) The total number of COVID19 cases. (b) The number of new cases confirmed each 24 h period. (c) The total number of deaths
associated with COVID-19. (d) The number of new deaths reported each 24 h period.

Figure 3. The number of COVID-19 Cases and Deaths in 19 in Select Countries in the
European Region. The cumulative case total of COVID-19 (SARS-CoV-2) for each country as
reported by the World Health Organization (WHO) daily COVID-19 Situation Reports (1 – 63).
This includes cases reported from the 21st of January to the 30th of March 2020. (a) The total
number of COVID-19 cases. (b) The number of new cases confirmed each 24 h period. (c) The
total number of deaths associated with COVID-19. (d) The number of new deaths reported each
24 h period. The black solid arrow represents the day Italy entered a nationwide lockdown. The
black dotted line represents two weeks since the start of the lockdown measures, which overlaps
with the incubation period of SARS-CoV-2.

Figure 4. The number of COVID-19 Cases and Deaths in 19 in Select Countries in the
Western Pacific Region. The cumulative case total of COVID-19 (SARS-CoV-2) for each country
as reported by the World Health Organization (WHO) daily COVID-19 Situation Reports (1 – 63).
This includes cases reported from the 21st of January to the 30th of March 2020. (a) The total
number of COVID-19 cases. (b) The number of new cases confirmed each 24 h period. (c) The
total number of deaths associated with COVID-19. (d) The number of new deaths reported each
24 h period.

Figure 5. The number of COVID-19 Cases and Deaths in 19 in Select Countries in SouthEast Asia and the Eastern Mediterranean Regions. The cumulative case total of COVID-19
(SARS-CoV-2) for each country as reported by the World Health Organization (WHO) daily
COVID-19 Situation Reports (1 – 63). This includes cases reported from the 21st of January to the
30th of March 2020. (a) The total number of COVID-19 cases. (b) The number of new cases
confirmed each 24 h period. (c) The total number of deaths associated with COVID-19. (d) The
number of new deaths reported each 24 h period.

Figure 6. COVID-19 Potential Modes of Transmission. This illustration shows three potential
ways SARS-CoV-2 can spread from an infected host to a susceptible host. First, it is transmitted
person to person (direct contact) through respiratory droplets. These droplets can travel for
distances 6 feet or less in air. Second, SARS-CoV-2 is likely transmitted through fomites (indirect
contact) for the duration it is viable on environmental surfaces. Third, it is also likely transmitted
through aerosols (indirect contact) for distances longer than 6 feet in the air. To establish an
infection, SARS-CoV-2 needs to first reach an entry point (eyes, nose or mouth) on a susceptible
host.

